Andalucía Streamlines Breast Cancer Screening with “One-Stop” Protocol
Table of Contents
New regulations, effective January 12th, mandate comprehensive testing for women with high-risk mammogram results, aiming to reduce uncertainty and accelerate diagnosis.
Andalucía is implementing a significant overhaul of its breast cancer screening protocol, mandating that women with mammogram results indicating a high probability of a tumor – specifically, a BI-RADS score of 4 or 5 – will now be eligible for a “one-stop” diagnostic process. Beginning January 12th, these patients will be able to undergo mammography, ultrasound, and biopsy on the same day, a practice previously recommended but not universally required. The move comes in response to recent failures in the region’s screening program and seeks to improve the speed and efficiency of cancer detection.
From Recommendation to Obligation
Previously, the “one-stop” approach was outlined in the Integrated Assistance Process for Breast Cancer but was considered a “good practice recommendation” rather than a mandatory organizational requirement. Some hospitals, such as the Hospital San Juan de Dios del Aljarafe, had already adopted the protocol independently. However, the new directive, spearheaded by the President of the Junta, Juanma Moreno, elevates the practice to a “standard of mandatory compliance” across all centers in Andalucía.
This standardization aims to ensure consistent access to timely diagnostics, regardless of provincial location or individual hospital resources. According to officials, the goal is to “guarantee it as a real assistance right for all women.” Hospitals have until February 28th to fully adapt to the new procedures.
Accelerated Diagnostics and Patient Benefits
The change is expected to significantly reduce the time it takes to confirm or rule out a cancer diagnosis. “This decision is important and will mean the completion of all tests in a single act without women having to travel ‘anywhere,’” stated Antonio Sanz, the Counselor for Presidency, Health and Emergencies, during a press conference in Málaga. He emphasized that the protocol will be guaranteed across all 32 breast units in Andalucía.
The new protocol seeks to minimize patient anxiety, improve continuity of care, and streamline the diagnostic process. Exceptions will be permitted in specific circumstances, such as patients on anticoagulants requiring pre-procedure preparation, those needing a stereotactic biopsy requiring specialized facilities, or individuals who choose to postpone their appointment.
Concerns Raised Over Exclusion of BI-RADS 3 Patients
While the new protocol addresses concerns related to high-risk cases, it has drawn criticism for excluding women with a BI-RADS 3 rating – those whose mammograms are deemed “probably benign.” These patients were disproportionately affected by the previous screening failures and experienced significant delays in diagnosis.
Ángela Claverol, president of the Amama Association, accused the Junta of “playing with words” by omitting BI-RADS 3 patients from the “one-stop” process. “The problems occurred in BI-RADS 3 and they have been left out,” she stated during a meeting with Antonio Maíllo, the federal coordinator of Izquierda Unida. Critics argue that excluding this group perpetuates the existing inequities and fails to address the full scope of the screening failures.
Additional Support Measures Announced
Alongside the diagnostic protocol changes, the Andalusian government has committed to providing financial assistance for individuals requiring hair prostheses as a result of chemotherapy treatment – a long-standing demand from patient advocacy groups like Amama. This support will be offered in conjunction with the mandated one-stop shop for BI-RADS 4-5 diagnoses, encompassing mammography, ultrasound, and biopsy in a single appointment.
The implementation of this new protocol represents a significant step towards improving breast cancer screening and diagnosis in Andalucía, though questions remain regarding the equitable treatment of all patients affected by past screening errors.
